Liquid preparation for treating visual impairment and injury
A technology for liquid preparations and visual impairments, which is applied in the field of liquid preparations for the treatment of visual impairments and injuries. It can solve problems such as insufficient attention to sub-health, eye diseases that cannot be underestimated, and eye treatment that cannot be used to maintain clear vision and improve nerve conduction. and vision, the effect of eliminating visual fatigue
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0018] Embodiment 1: A kind of liquid preparation for treating visual impairment and damage, it is to add blueberry fruit juice powder, lutein ester, zeaxanthin, grape seed extract, Haematococcus pluvialis, vitamin C, Oral agent drink made of taurine.
[0019] The drink of this embodiment contains 167 mg of Haematococcus pluvialis, 67 mg of lutein, 6.7 mg of zeaxanthin, 100 mg of blueberry juice powder, 20 mg of grape seed extract, 1000 mg of vitamin C and 60 mg of taurine per 100 ml.
[0020] This embodiment is subpackaged into 15ml / bottle of product, taken once a day, no more than 15ml each time, not only suitable for young people with vision loss caused by excessive use of eyes, but also suitable for visual impairment and degeneration, caused by three advanced chronic diseases Elderly population with ocular lesions.
[0021] This embodiment is generally taken continuously for about 7 days, and discomfort symptoms such as dry eyes and soreness can be alleviated; after takin...
Embodiment 2
[0022] Embodiment 2: clinical trial curative effect
[0023] This embodiment selects 60 patients who are diagnosed as asthenopia through eye examination. The patients show blurred vision, dry eyes, inability to see things at close range, dizziness and other symptoms. The patients who enter the test are all excluded from other ophthalmic diseases, neurasthenia and Trigeminal neuralgia. The selected patients were randomly divided into the control group and the observation group according to the lottery method, with 30 cases in each group. In the control group, there were 14 male patients and 16 female patients, aged 16-42 years, with an average (28.3±1.4) years old; in the observation group, there were 17 male patients and 13 female patients, aged 15-45 years, with an average ( 27.65±1.5) years old. There was no statistically significant difference in gender and age between the two groups (P>0.05).
[0024] The control group was treated with Zhuzhu Mingmu Eye Drops (Pharmaceu...
Embodiment 3
[0032] Embodiment 3: typical case
[0033] Case 1: Ye, female, 28 years old, was diagnosed with dry eye syndrome through slit lamp and visual acuity examinations due to the sensation of foreign body and dryness in her eyes, accompanied by symptoms such as red eyes and photophobia. She took this medicine continuously After 1 month of the drink of Invention Example 1, its symptoms all took a turn for the better, corneal staining decreased, and tear fluid secretion increased.
[0034] Case 2: Guo, female, 66 years old, because her eyes felt floating with small black shadows, she was checked and diagnosed with floaters. After taking the drink of Example 1 of the present invention continuously for 40 days, her symptoms all improved. It got better, and the self-report felt that the black shadow in front of the eyes was reduced.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com